TI
IONS icon

Turner Investments’s Ionis Pharmaceuticals IONS Stock Holding History

Turner Investments’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-45,360
Closed -$2.17M – 241
2016
Q4 		$2.17M Buy
45,360
+2,820
+7% +$112K 0.88% 31
2016
Q3 		$1.56M Buy
+42,540
New +$1.33M 0.52% 67
2015
Q2 		– Sell
-3,900
Closed -$248K – 326
2015
Q1 		$248K Buy
+3,900
New +$265K 0.04% 286

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Turner Investments's IONS Position: Q1 2017 in Review

Turner Investments sold out of Ionis Pharmaceuticals (IONS) in Q1 2017, closing a stake of 45,360 shares — an estimated $2.17M sold.

Turner Investments first reported a position in IONS in Q1 2015 and held it in 3 quarters. The position peaked at $2.17M in Q4 2016. 270 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

  • Turner Investments reported no remaining Ionis Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 45,360 Ionis Pharmaceuticals shares in Q1 2017, an estimated $2.17M.
  • Turner Investments first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Turner Investments's Ionis Pharmaceuticals position peaked at $2.17M in Q4 2016.
  • 270 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.